ROCKVILLE, MD--(Marketwire - December 17, 2008) - Seegene, Inc., a leader in multi-pathogen diagnostic testing, today announced that it has been awarded international patent protection for a break-through technology able to accelerate the detection of highly personal variations in genetic sequences. These genetic variations can identify an individual’s risks for a broad range of disorders, such as Alzheimer’s disease and coronary artery diseases, or genetic mutations known to cause various cancers.
